by Tom Ruginis | Apr 25, 2018 | Business |
One of the key values Perlara was founded on is transparency, and a commitment to open business practices. To that end, and to help other entrepreneurs get an idea of what it’s like to launch and run a biotech start-up, we’ve been posting regular updates about...
by Tom Ruginis | Dec 28, 2017 | Start-ups |
When we last checked in a year ago, Perlara had just achieved three critical milestones: a product (PerlQuest), a validating Pharma deal, and first revenue – a small check, but revenue nonetheless. Over the course of 2017, we transitioned from startup with a...
by Ethan Perlstein | Nov 4, 2017 | Start-ups, Uncategorized |
This week we announced a $7.4M equity financing. Endpoints News and STAT News covered the announcement and the Twitter angle. Here’s the backstory from the CEO’s vantage point. From the outside, this round appears to be our Series A. But it’s technically our...
by Tom Ruginis | Dec 13, 2016 | Start-ups |
As 2016 draws to a close, we look back on two and half years of Perlara spending. Let’s begin with burn rate. This figure shows our monthly burn since first cash inflows in April 2014: In 2014, we completed model validation and assay development for our lead discovery...
![Lean biotech startup]()
by Ethan Perlstein | Jan 17, 2015 | Start-ups |
PLab fits the mold of a lean startup but with a biotech twist. Over the course of 2014, our first year of existence, we grew bench by bench at QB3@953, the biotech incubator we call home. Every aspect of overhead is itemized, from individual autoclave runs to monthly...
